Clinical Trials List
2022-04-01 - 2028-09-30
Phase III
Not yet recruiting8
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/15
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Huey-En Tzeng 無
- Kuan-Der Lee 未分科
- Cheng-I Hsieh 無
- Jia-Ruey Tsai 無
- Huan-Tze Lin 無
- Kai-Ling Lee 無
- Chun-Liang Chou 無
- Han-Pin Kuo 無
- Mei-Chuan Chen 無
- 黃柔蓁 無
- Chi-Li Chung 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO 未分科
- Chong-Jen Yu 未分科
- 吳尚俊 未分科
- 廖唯昱
- 廖斌志 Division of Hematology & Oncology
- 徐偉勛
- Jih-Hsiang Lee
- Chia-Chi Lin
- CHAO-WEN LIN
- James Chih-Hsin Yang
- 楊景堯
- 蔡子修
- 許嘉林
- 錢穎群
- 陳冠宇
- 黃俊凱
- YEN-TING LIN
- 黃得瑞
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
698 participants
